Under construction – not a live service
Sign in

Chronic myeloid leukaemia: open trials in Spain

18 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

  • 2026-525234-39-00

    A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

    Trial Treatment · Phase 1 · Janssen Cilag International

    Hospital Clinic de Barcelona, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Clínica Universidad de navarra, Pamplona

    Registry updated 2026-11-06

  • NCT06788509

    A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

    Trial Treatment · Phase 1 · Janssen Research & Development, LLC

    Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca

    Registry updated 2026-11-04

  • NCT06163430

    A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)

    Trial Treatment · Phase 1/2 · Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

    Institut Catala d'Oncologia, Badalona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · El Hospital Universitario De Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario de la Princesa, Madrid · Hospital QuirónSalud Zaragoza, Zaragoza

    Registry updated 2026-10-15

  • NCT07354074

    Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

    Trial Treatment · Phase 2 · Novartis Pharmaceuticals

    Barcelona · Madrid

    Registry updated 2026-10-15

  • NCT03934372

    Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

    Trial Treatment · Phase 1/2 · Incyte Biosciences International Sàrl

    Hospital General Universitario Vall D Hebron, Barcelona · Hospital Sant Joan de Deu de Manresa, Barcelona · Hospital Infantil Unversitario Nino Jesus, Madrid · Hospital Universitari i Politécnic La Fe, Valencia

    Registry updated 2026-10-09

  • NCT04256317

    A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

    Trial Treatment · Phase 2/3 · Taiho Oncology, Inc.

    Institut Catala d'Oncologia, Badalona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital San Pedro De Alcántara, Cáceres · Hospital Universitari de Girona Doctor Josep Trueta, Girona · Hospital Universitario Virgen de las Nieves, Granada · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario La Paz, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · MD Anderson Cancer Center, Madrid · Clinica Universidad de Navarra, Madrid · Hospital Quironsalud Malaga, Málaga · Hospital Universitario Central De Asturias, Oviedo · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Y Politecnico La Fe, Valencia

    Registry updated 2026-10-06

  • NCT04996875

    (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

    Trial Treatment · Phase 2 · Cogent Biosciences, Inc.

    Hospital Universitario Vall d'Hebron, Barcelona · Institut Catala d Oncologia Hospital Duran i Reynals, Barcelona · Hospital Universitario Ramón y Cajal, Madrid

    Registry updated 2026-09-15

  • NCT06423911

    Study of Olverembatinib (HQP1351) in Patients With CML-CP

    Trial Treatment · Phase 3 · Ascentage Pharma Group Inc.

    Institut Catala d'Oncologia, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario del Vinalopo, Elche · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Infanta Leonor, Madrid · Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario Regional de Málaga, Málaga · Hospital Universitario Virgen de la Victoria, Málaga · University Clinical Hospital Virgen De La Arrixaca, Murcia · Complejo Hospitalario Universitario de Ourense, Ourense · Hospital Universitario Dr. Peset Aleixandre, Valencia · Hospital Universitario Miguel Servet, Zaragoza

    Registry updated 2026-09-15

  • 2025-522138-29-00

    Study to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia.

    Trial Treatment · Phase 2 · Novartis Pharma AG

    Hospital Universitari Vall d'Hebron, Barcelona · Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital Universitario La Paz, Madrid

    Registry updated 2026-08-31

  • NCT04093570

    A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

    Trial Treatment · Phase 2 · Taiho Oncology, Inc.

    Hospital HM Nou Delfos, Barcelona · Hospital Universitari Arnau De Vilanova De La Gerencia Territorial De Lleida, Lleida · Hospital San Pedro, Logroño · Hospital Universitario La Paz, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario HM Sanchinarro, Madrid · University Clinical Hospital Virgen De La Arrixaca, Murcia

    Registry updated 2026-07-28

  • NCT07719348

    A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

    Trial Treatment · Phase 1/2 · Servier

    Hospital Universitari Vall d'Hebron, Barcelona · Clinica Universidad de Navarra, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario Y Politecnico La Fe, Valencia

    Registry updated 2026-07-22

  • NCT04877522

    Asciminib Roll-over Study

    Trial Treatment · Phase 4 · Novartis Pharmaceuticals

    Institut Catala d'Oncologia, Badalona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Basurto, Bilbao · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario de la Princesa, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia

    Registry updated 2026-07-06

  • 2025-521126-15-00

    Safety and efficacy of treatment combination with ponatinib and asciminib in chronic myeloid leukemia patients resistant to ponatinib and/or asciminib

    Trial Treatment · Phase 2 · Grupo Espanol De Leucemia Mieloide Cronica (GELMC)

    Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Basurto, Bilbao · El Hospital Universitario De Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Regional de Málaga, Málaga · Hospital General Universitario Morales Meseguer, Murcia · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Y Politecnico La Fe, Valencia

    Registry updated 2026-06-01

  • NCT05304377

    A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

    Trial Treatment · Phase 1 · Enliven Therapeutics

    Hospital del Mar, Barcelona · Hospital Universitario La Paz, Madrid · Hospital Universitario Y Politecnico La Fe, Valencia

    Registry updated 2026-04-01

  • NCT03850574

    Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

    Trial Treatment · Phase 1/2 · Aptose Biosciences Inc.

    Hospital General Universitario de Alicante, Alicante · Fir Huvh Fundacio Institut De Recerca Hospital Universitari Vall De Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Central De Asturias, Oviedo · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario De Salamanca, Salamanca · Hospital Clinico Universitario de Valencia, Valencia · Hospital Universitario Y Politecnico La Fe, Valencia

    Registry updated 2025-08-26

  • NCT07082452

    A Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard Continuous Venetoclax Exposure Combined With Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction

    Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris

    Hospital General Universitario de Albacete, Albacete · Hospital General Universitario Dr. Balmis, Alicante · Hospital Universitario Hermanos Trias y Pujol. Institut Catalá d'Oncología (ICO), Badalona · Hospital San Pedro De Alcántara, Cáceres · Hospital Universitario Reina Sofia, Córdoba · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitari Mutua Terrassa, Terrassa · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Clinico Universitario de Valencia, Valencia · Hospital Universitario Dr. Peset Aleixandre, Valencia

    Registry updated 2025-07-24

  • NCT06409936

    PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML

    Trial Treatment · Phase 2 · Gruppo Italiano Malattie EMatologiche dell'Adulto

    Institut Catala d'Oncologia, Badalona · Hospital del Mar, Barcelona · Hospital Universitario Basurto, Bilbao · Institut Català d'Oncologia, Girona · Hospital Universitario Virgen de las Nieves, Granada · El Hospital Universitario De Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria · Hospital Universitario De Leon, León · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario La Paz, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · University Clinical Hospital Virgen De La Arrixaca, Murcia · Hospital Universitario De Salamanca, Salamanca · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Y Politecnico La Fe, Valencia

    Registry updated 2025-07-08

  • NCT01281735

    International Chronic Myeloid Leukemia Pediatric Study

    Research · Poitiers University Hospital

    Officina Proyectos SEHOP, Palma de Mallorca

    Registry updated 2024-01-17

All Chronic myeloid leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Under construction, not live – Chronic myeloid leukaemia trials in Spain – Frontlight Research